This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

The Role of Physical Activity in the Treatment of Children With Type 1 Diabetes. (4301)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2007 by Rabin Medical Center.
Recruitment status was:  Not yet recruiting
Information provided by:
Rabin Medical Center Identifier:
First received: June 25, 2007
Last updated: NA
Last verified: June 2007
History: No changes posted
Randomized, controlled, open, comparative intervention study in two groups, each consisting of 25 children with type 1 diabetes that will undergo twelve weeks of exercise program (intensive arm) and twelve weeks of regular activity (non intensive arm) separated by four week of washout period. The study will be conducted in a crossover manner: one group starting with the intensive arm followed by the non intensive arm and vice versa. Blood glucose, HbA1C, Fructosamine, 3 days continuous glucose monitoring system (CGMS), total daily insulin dose, fasting lipid profile, body impedance and BMR will be measured. Self esteem and quality of life questionnaires will be filled.

Condition Intervention
Type 1 Diabetes Behavioral: Intensive Physical activity Behavioral: Control- regular physical activity

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Randomized,Controlled,Open,Cross-Over Intervention Study for Evaluating the Role of Physical Activity in the Treatment of Children With Type 1 Diabetes.

Resource links provided by NLM:

Further study details as provided by Rabin Medical Center:

Primary Outcome Measures:
  • HbA1C [ Time Frame: 0,3 monthes ]
  • fructosamine [ Time Frame: 0,3 monthes ]

Secondary Outcome Measures:
  • Body composition & BMR [ Time Frame: 0,3 monthes ]
  • Self esteem & QOL questionnaires [ Time Frame: o, 3 monthes ]
  • 3 days CGMS & SBGM profile [ Time Frame: 0,3 monthes ]

Estimated Enrollment: 2007
Study Start Date: July 2007
Estimated Study Completion Date: July 2009
  Show Detailed Description


Ages Eligible for Study:   8 Years to 16 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Type I diabetic children
  2. Tanner stage II-IV
  3. Patients of the Schneider's national institute of childhood diabetes. Duration of diabetes
  4. more than one year.
  5. HbA1C between 8 and 12 at time 0.
  6. Mandatory 4 daily self blood glucose measurements and daily recording of adverse events.
  7. A signed informed consent of the parents and child.

Exclusion Criteria:

  1. Additional chronic significant disease such as cardiac, liver, renal disease .
  2. Children who exercise regularly more than 180 min per week.
  3. Cardiac symptoms: history of chest pain , syncope , palpitations or dyspnea during exercise.
  4. Eating disorders.
  5. Participation in a study during the past month.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00491465

Contact: Ravital Nimri, MD 972-39253778 ext direct

Schnider children's medical center Not yet recruiting
Petach-Tikva, Israel
Principal Investigator: Ravital Nimri, MD         
Principal Investigator: Moshe Phillip, Prof.         
Sub-Investigator: Rachel Frumkin, MD         
Sub-Investigator: Neomi Weintrob, MD         
Sub-Investigator: Shlomit Shalitin, MD         
Sub-Investigator: Nesia Nagelberg, MA         
Sponsors and Collaborators
Rabin Medical Center
Principal Investigator: Ravital Nimri, MD Rabin Medical Center
Principal Investigator: Moshe Phillip, Prof Rabin Medical Center
  More Information Identifier: NCT00491465     History of Changes
Other Study ID Numbers: rmc074301ctil
Study First Received: June 25, 2007
Last Updated: June 25, 2007

Keywords provided by Rabin Medical Center:
Type 1 Diabetes, physical activity, pediatric, metabolic control

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 1
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Autoimmune Diseases
Immune System Diseases processed this record on September 21, 2017